We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
BellRing Brands
BRBR
$1.19B
| $39.1M | 0.07% |
674,267
-189,321
| -22% | -$12.6M |
|
302
Onto Innovation
ONTO
$17.9B
| $38.9M | 0.07% |
384,977
+296,691
| +336% | +$31.7M |
|
303
ATI
ATI
$29.2B
| $38.7M | 0.07% |
448,485
+5,462
| +1% | +$374K |
|
304
Woodward
WWD
$20.4B
| $38.5M | 0.07% |
157,096
-19,387
| -11% | -$3.97M |
|
305
Incyte
INCY
$25.9B
| $38.4M | 0.07% |
563,153
-147,222
| -21% | -$9.33M |
|
306
Parker-Hannifin
PH
$127B
| $37.9M | 0.07% |
54,232
-660
| -1% | -$417K |
|
307
Legend Biotech
LEGN
$3.99B
| $37.8M | 0.07% |
1,063,724
-327,947
| -24% | -$10.6M |
|
308
Wells Fargo
WFC
$257B
| $37.7M | 0.07% |
470,110
-21,236
| -4% | -$1.53M |
|
309
RTX Corp
RTX
$286B
| $37.6M | 0.07% |
257,674
-24,185
| -9% | -$3.22M |
|
310
ACM Research
ACMR
$5.61B
| $36.8M | 0.07% |
1,421,688
+348,936
| +33% | +$7.85M |
|
311
CenterPoint Energy
CNP
$25.9B
| $36.8M | 0.07% |
1,001,954
-144,530
| -13% | -$5.36M |
|
312
Gaming and Leisure Properties
GLPI
$12.3B
| $36.8M | 0.07% |
788,397
-40,245
| -5% | -$1.9M |
|
313
AutoZone
AZO
$47.9B
| $36.3M | 0.07% |
9,783
+2,016
| +26% | +$7.43M |
|
314
SharkNinja
SN
$27.2B
| $36.2M | 0.07% |
365,560
-940,211
| -72% | -$81.3M |
|
315
Power Integrations
POWI
$3.09B
| $36.1M | 0.07% |
646,476
-67,537
| -9% | -$3.47M |
|
316
Brunswick
BC
$5.03B
| $36.1M | 0.07% |
654,151
-224,234
| -26% | -$11.3M |
|
317
Hubbell
HUBB
$24.8B
| $36.1M | 0.07% |
88,290
+6,920
| +9% | +$2.57M |
|
318
XPO
XPO
$22.4B
| $36M | 0.07% |
285,319
-501
| -0.2% | -$56.2K |
|
319
Autohome
ATHM
$2.6B
| $35.9M | 0.07% |
1,393,033
+530,152
| +61% | +$13.7M |
|
320
Kroger
KR
$34.9B
| $35.7M | 0.07% |
497,093
-9,845
| -2% | -$680K |
|
321
Exelixis
EXEL
$13.7B
| $35.3M | 0.07% |
801,604
+317,866
| +66% | +$12.7M |
|
322
Hartford Financial Services
HIG
$37.3B
| $35.3M | 0.07% |
278,152
-1,447
| -0.5% | -$180K |
|
323
Synchrony
SYF
$26B
| $34.8M | 0.07% |
521,025
-17,259
| -3% | -$965K |
|
324
Floor & Decor
FND
$5.68B
| $34.7M | 0.07% |
457,065
-229
| -0.1% | -$17K |
|
325
Northrop Grumman
NOC
$77.4B
| $34.7M | 0.07% |
69,431
+35,538
| +105% | +$17.5M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.